Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Innocenti

Showing results (31-40 of 186) with videos related to

Pageof 19
Sort By:
Pharmacotherapy|May 28, 2008
Pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 polymorphisms: are we there yet?Minoli A Perera, Federico Innocenti, Mark J Ratain
British Journal of Clinical Pharmacology|July 18, 2006
The role of pharmacogenetics in cancer therapeuticsWei Peng Yong, Federico Innocenti, Mark J Ratain
Seminars in Oncology|March 23, 2011
The use of genomic information to optimize cancer chemotherapyFederico Innocenti, Nancy J Cox, M Eileen Dolan
Clinical Pharmacology and Therapeutics|June 11, 2021
Pharmacogenomic-Guided Therapy in Colorectal CancerRobert B Diasio, Federico Innocenti, Steven M Offer
Oncogene|October 7, 2003
Pharmacogenomics: road to anticancer therapeutics nirvana?Apurva A Desai, Federico Innocenti, Mark J Ratain
Pharmacogenetics|August 2, 2003
UGT pharmacogenomics: implications for cancer risk and cancer therapeuticsApurva A Desai, Federico Innocenti, Mark J Ratain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 26, 2006
Irinogenetics: what is the right star?Federico Innocenti, Everett E Vokes, Mark J Ratain
British Journal of Clinical Pharmacology|May 25, 2013
Implications of genome-wide association studies in cancer therapeuticsJai N Patel, Howard L McLeod, Federico Innocenti
Plos One|April 27, 2007
Searching for tissue-specific expression pattern-linked nucleotides of UGT1A isoformsWei Zhang, Wanqing Liu, Federico Innocenti, et al.
Clinical Chemistry and Laboratory Medicine|September 29, 2011
Recent progress and clinical importance on pharmacogenetics in cancer therapyThomas I Peng Soh, Wei Peng Yong, Federico Innocenti
Pageof 19

Showing results (31-40 of 186) with videos related to

Sort By:
Pageof 19
Pharmacotherapy|May 28, 2008
Pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 polymorphisms: are we there yet?Minoli A Perera, Federico Innocenti, Mark J Ratain
British Journal of Clinical Pharmacology|July 18, 2006
The role of pharmacogenetics in cancer therapeuticsWei Peng Yong, Federico Innocenti, Mark J Ratain
Seminars in Oncology|March 23, 2011
The use of genomic information to optimize cancer chemotherapyFederico Innocenti, Nancy J Cox, M Eileen Dolan
Clinical Pharmacology and Therapeutics|June 11, 2021
Pharmacogenomic-Guided Therapy in Colorectal CancerRobert B Diasio, Federico Innocenti, Steven M Offer
Oncogene|October 7, 2003
Pharmacogenomics: road to anticancer therapeutics nirvana?Apurva A Desai, Federico Innocenti, Mark J Ratain
Pharmacogenetics|August 2, 2003
UGT pharmacogenomics: implications for cancer risk and cancer therapeuticsApurva A Desai, Federico Innocenti, Mark J Ratain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 26, 2006
Irinogenetics: what is the right star?Federico Innocenti, Everett E Vokes, Mark J Ratain
British Journal of Clinical Pharmacology|May 25, 2013
Implications of genome-wide association studies in cancer therapeuticsJai N Patel, Howard L McLeod, Federico Innocenti
Plos One|April 27, 2007
Searching for tissue-specific expression pattern-linked nucleotides of UGT1A isoformsWei Zhang, Wanqing Liu, Federico Innocenti, et al.
Clinical Chemistry and Laboratory Medicine|September 29, 2011
Recent progress and clinical importance on pharmacogenetics in cancer therapyThomas I Peng Soh, Wei Peng Yong, Federico Innocenti
Pageof 19